Antiepileptic agents affect hypothalamic beta-endorphin concentrations.
beta-Endorphin, Met-enkephalin, substance P, and somatostatin concentrations were evaluated in the hypothalami of rats treated either acutely or chronically (15 days) with sodium valproate, diphenylhydantoin, phenobarbital, or ethosuximide. All of these drugs, with the exception of ethosuximide, induced significant decreases in beta-endorphin concentrations after acute treatment, while only sodium valproate induced a decrease after chronic treatment. The acute and chronic effects of sodium valproate were also produced by aminooxyacetic acid, an inhibitor of gamma-aminobutyric acid (GABA) transaminase, while another GABA transaminase inhibitor, ethanolamine-O-sulphate, and THIP, a GABA receptor agonist, were effective after acute administration. Metenkephalin, substance P, and somatostatin concentrations were never affected by the drugs used. The present results, indicating that antiepileptic agents specifically decrease beta-endorphin concentrations, seem to correlate well with the capacity of these agents to blunt the epileptic activity of the peptides tested. Moreover, our data suggest that GABA may be involved in the anticonvulsant-induced reduction of beta-endorphin concentrations.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D004723:Endorphins / Q000378:metabolism*; D005013:Ethosuximide / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin / Q000378:metabolism; D013373:Substance P / Q000378:metabolism; D014635:Valproic Acid / Q000494:pharmacology; D001615:beta-Endorphin
D000927:Anticonvulsants; D004723:Endorphins; D013373:Substance P; D013004:Somatostatin; D005013:Ethosuximide; D001615:beta-Endorphin; D014635:Valproic Acid; D010672:Phenytoin; D010634:Phenobarbital